Amoroso, Jennifer I.

HRN: 18-44-05  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/20/2022
CEFUROXIME 1.5GM (VIAL)
09/20/2022
09/20/2022
IVTT
1.5gm
LD
Stat CS
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Skin & Soft TissueIntra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: